
Insitu Pharma Private Limited
Founded in 2017 and headquartered in Telangana, India.
Founded in 2017 and headquartered in Telangana, India.
K.V.Rangareddy, Telangana, India
+91-XXXXXXXXXX
U24100TG2017PTC115112
115112
Private Limited Indian Non-Government Company
09 Feb 2017
30 Sep 2019
31 Mar 2019
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkata Chaikam ![]() | Director | 09-Feb-2017 | Current |
Satyanarayana Chaduvu ![]() | Director | 09-Feb-2017 | Current |
Enhance accessibility to Insitu Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Insitu Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Venkata Chaikam is a mutual person
Venkata Chaikam is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Insitu Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Insitu Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Insitu Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Insitu Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Insitu Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
Venkata Ramana Reddy Chaikam was appointed as a Director was appointed as a Director on 09 Feb 2017 & has been associated with this company since 8 years 3 months .
Satyanarayana Chaduvu was appointed as a Director was appointed as a Director on 09 Feb 2017 & has been associated with this company since 8 years 3 months .
Insitu Pharma Private Limited was registered on 09 Feb 2017 with Roc Hyderabad & aged 8 years 3 months as per MCA records.
Insitu Pharma Private Limited was incorporated on 09 Feb 2017.
The authorized share capital of Insitu Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Insitu Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Insitu Pharma Private Limited is Flat No. 701 B Block Vertex Sadguru Krupa, Hydernagar, Hyderabad Rangareddi, Telangana, India, 500090.
The corporate identification number (CIN) of Insitu Pharma Private Limited is U24100TG2017PTC115112 and the company number is 115112 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Insitu Pharma Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.